Skip to main content
Pangenomic Health Inc. logo

Pangenomic Health Inc. — Investor Relations & Filings

Ticker · NARA ISIN · CA69842E4031 LEI · 254900SLZH0JK1QM2B67 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 202 across all filing types
Latest filing 2026-05-01 Regulatory Filings
Country CA Canada
Listing CSE NARA

About Pangenomic Health Inc.

https://pangenomic.com/

Pangenomic Health Inc. is a precision health company focused on improving individual health outcomes using smart-tech and evidence-based natural health solutions. The company develops digital platforms that deliver personalized, plant-based treatments, primarily targeting mental wellness. Its portfolio includes the Nara app, which curates natural remedies and personalized insights for mental health management; MUJN Diagnostics, a clinical decision support platform offering biomarker testing and symptom tracking for brain health; AGENTA Health, an AI-driven tool for personalized supplement and longevity plans; and Mindleap, an app providing mental health tracking and professional services access. Pangenomic aims to provide individuals and healthcare practitioners with precision natural remedy options.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2026-05-01 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2026-05-01 English
Annual MD&A - English.pdf
Regulatory Filings
2026-05-01 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2026-05-01 English
Audited annual financial statements – English.pdf
Regulatory Filings
2026-05-01 English
News release - English.pdf
Capital/Financing Update Classification · 72% confidence The document is a “supplément de fixation du prix” (pricing supplement) to a base prospectus for the issuance of structured notes by CIBC. It details the terms, pricing, and conditions of a debt offering (medium-term notes), which constitutes a financing activity. There is no indication that this is an earnings release, management update, legal proceeding, or other category. Therefore, the document is best classified as a Capital/Financing Update.
2026-04-14 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.